Immix Biopharma (IMMX) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 22, 2026, at the company's Los Angeles office.

• Proxy materials and 2025 annual report are available online for shareholder review.

• Shareholders can request paper or email copies of proxy materials at no charge.

Voting matters and shareholder proposals

• Shareholders will vote on the election of nine directors and ratification of Crowe LLP as independent auditor for fiscal year ending December 31, 2026.

• Board recommends voting "FOR" all director nominees and auditor ratification.

Board of directors and corporate governance

• Nine director nominees: Ilya Rachman, Gabriel Morris, Jason Hsu, Magda Marquet, Helen C. Adams, Carey Ng, Jane Buchan, Yekaterina Chudnovsky, and Nancy Chang.